Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI-Powered ECG may spot hidden heart risks before damage occurs

NCT ID NCT07355023

Recruiting now Knowledge-focused Sponsor: Tri-Service General Hospital Source: ClinicalTrials.gov ↗

First seen Jan 21, 2026 · Last updated May 13, 2026 · Updated 17 times

Summary

This study looks at whether artificial intelligence can analyze electrocardiograms (ECGs) to identify people at high risk for developing left ventricular dysfunction, a condition where the heart's main pumping chamber weakens. Researchers will review medical records from 5,000 adults with normal heart function to see if early treatment with standard heart medications can prevent future decline. The goal is to learn if AI-guided screening can help doctors intervene sooner and protect heart health.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEFT VENTRICULAR (LV) SYSTOLIC DYSFUNCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tri-Service General Hospital

    RECRUITING

    Taipei, Taipei, 11490, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

LEFT VENTRICULAR (LV) SYSTOLIC DYSFUNCTION